Stock Movers: Canada Goose, Celsius, and Moderna Stock Performance

Canada Goose Stock Performance

• 📉 Canada Goose shares experienced a significant drop, down as much as 9% intra-day and closing 3.5% lower, with the stock down 20% for the year.
• ⚠️ Barclays downgraded the stock to "underweight" from "equal weight," citing challenging macro pressures and difficult retail sentiment.
• 📊 Goldman Sachs estimates that Canada Goose could be one of the worst-hit retail stocks due to its reliance on sourcing from Canada, potentially impacted by tariffs.

Celsius Holdings Growth

• 📈 Celsius Holdings shares rose to their highest intraday level since September, gaining 7% today.
• 🚀 Truist Securities upgraded the stock to "buy" from "hold," highlighting the company’s strong position in the women's energy drink segment following the Alani Nu acquisition.
• 🎯 The growth strategy focuses on the rapidly expanding female demographic in the energy drink market, while the male segment is flatlining or declining.
• 💡 Despite a competitive market and a 50% stock decline last year, Celsius is up 35% year-to-date, indicating a successful current strategy.

Moderna and Vaccine Stock Plunge

• 💉 Moderna was the biggest loser, closing 9% lower and falling as much as 14% intra-day, with a 30% year-to-date loss.
• ⚠️ The plunge occurred after Peter Marks, a key FDA regulator overseeing vaccine and gene therapy approvals, resigned.
• 📉 Marks' resignation is attributed to friction with Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine critic.
• 🗣️ Analysts from firms like Cantor Fitzgerald have expressed strong negative reactions, criticizing the leadership and suggesting the administration should reevaluate its stance.